The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis)
- PMID: 39373543
- DOI: 10.1093/ced/llae400
The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis)
Erratum in
-
Correction to: The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis).Clin Exp Dermatol. 2025 Jun 25;50(7):1486. doi: 10.1093/ced/llaf175. Clin Exp Dermatol. 2025. PMID: 40373079 No abstract available.
Conflict of interest statement
Conflicts of interest: The authors declare no conflicts of interest.
References
LinkOut - more resources
Full Text Sources
